Theratechnologies Inc Corporate Analyst Meeting Transcript
Okay. Good afternoon, everyone. Thank you for joining us today. My name is Philippe Dubuc, Senior Vice President and Chief Financial Officer of Theratechnologies. It's a pleasure for us to welcome you today to our first R&D day, which is an opportunity for us to bring everyone up to speed on the development programs at Theratechnologies, especially in what has happened in the next -- probably in the past 6 to 9 months.
So I'll just take a moment to go through the agenda for today. We're going to start off with Luc Tanguay, who's going to say a few words. Luc, our President and CEO. Luc is going to say a few words and provide an overview of the company.
Luc will then go on to introduce Dr. Steven Grinspoon. Dr. Grinspoon is a longtime collaborator of Theratechnologies on EGRIFTA, and he will provide us with an overview of the recent study that was published on NAFLD/NASH for EGRIFTA. Dr. Grinspoon is being held up in Boston, so he'll be presenting by phone. Dr. Grinspoon is hosting a symposium this afternoon and could not
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |